LncRNA SNHG15 mediates 1-methyl-4-phenylpyridinium (MPP+)-induced neuronal damage through targeting miR-29c-3p/SNCA axis
出版年份 2022 全文链接
标题
LncRNA SNHG15 mediates 1-methyl-4-phenylpyridinium (MPP+)-induced neuronal damage through targeting miR-29c-3p/SNCA axis
作者
关键词
-
出版物
NEUROLOGICAL RESEARCH
Volume 45, Issue 2, Pages 181-190
出版商
Informa UK Limited
发表日期
2022-11-17
DOI
10.1080/01616412.2022.2129754
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SNHG15 knockdown inhibits diabetic nephropathy progression in pediatric patients by regulating the miR-141/ICAM-1 axis in vitro
- (2021) Jiewei Liu et al. BIOSCIENCE REPORTS
- LncRNA SNHG15 Knockdown Protects Against OGD/R-Induced Neuron Injury by Downregulating TP53INP1 Expression via Binding to miR-455-3p
- (2021) Yun Fan et al. NEUROCHEMICAL RESEARCH
- Parkinson's disease
- (2021) Bastiaan R Bloem et al. LANCET
- Diagnosis and Treatment of Parkinson Disease
- (2020) Melissa J. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson’s disease via the HPRT1-mediated Wnt/β-catenin signaling pathway
- (2020) Jingjing Jiang et al. Aging-US
- LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson’s disease via ablating microRNA-125b-5p
- (2020) Yan Fan et al. BRAIN RESEARCH BULLETIN
- MiR‐29c‐3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease
- (2020) Ruili Wang et al. GENES TO CELLS
- LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson’s Disease Through Regulating miR-585-3p/PIK3R3
- (2020) Yong Zhang et al. NEUROCHEMICAL RESEARCH
- Astaxanthin suppresses endoplasmic reticulum stress and protects against neuron damage in Parkinson's disease by regulating miR-7/SNCA axis
- (2020) Dong-Fang Shen et al. NEUROSCIENCE RESEARCH
- Long noncoding RNA NEAT1 knockdown inhibits MPP+-induced apoptosis, inflammation and cytotoxicity in SK-N-SH cells by regulating miR-212-5p/RAB3IP axis
- (2020) Ruiguang Liu et al. NEUROSCIENCE LETTERS
- LncRNA NEAT1 Regulates the Development of Parkinson’s Disease by Targeting AXIN1 Via Sponging miR-212-3p
- (2020) Tao Liu et al. NEUROCHEMICAL RESEARCH
- m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner
- (2019) Ruifan Wu et al. Cell Death & Disease
- Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson’s Disease Patients
- (2019) Maximilianos Elkouris et al. Frontiers in Cellular Neuroscience
- Emerging therapies in Parkinson disease — repurposed drugs and new approaches
- (2019) Ahmad Elkouzi et al. Nature Reviews Neurology
- α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
- (2019) Surabhi Mehra et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson’s disease through RAB3IP
- (2019) Qiuyu Lin et al. BIOLOGICAL CHEMISTRY
- Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
- (2019) David K. Simon et al. CLINICS IN GERIATRIC MEDICINE
- LncRNA SNHG15: A new budding star in human cancers
- (2019) You Shuai et al. CELL PROLIFERATION
- Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221/222 /p27/mTOR pathway in Parkinson's disease
- (2019) Chen Qian et al. EXPERIMENTAL CELL RESEARCH
- miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway
- (2019) Zhenhua Hu et al. CELL CYCLE
- The genetics of Parkinson disease
- (2018) Hao Deng et al. AGEING RESEARCH REVIEWS
- Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
- (2018) Xian-Si Zeng et al. Frontiers in Aging Neuroscience
- Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma
- (2018) Zhiyuan Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
- (2018) Boris Kantor et al. MOLECULAR THERAPY
- The Role of Long Noncoding RNAs in Central Nervous System and Neurodegenerative Diseases
- (2018) Chang-Wei Wei et al. Frontiers in Behavioral Neuroscience
- Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer’s Disease
- (2017) Yuquan Wu et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Free Radicals in Oxidative Stress-Related Human Diseases
- (2017) Patrik Poprac et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson’s Disease
- (2016) Yaohui Ni et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- How neuroinflammation contributes to neurodegeneration
- (2016) R. M. Ransohoff SCIENCE
- Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
- (2014) Anthony H V Schapira et al. LANCET
- Long non-coding RNAs: A new frontier in the study of human diseases
- (2013) Xuefei Shi et al. CANCER LETTERS
- Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
- (2013) Juliet M. Taylor et al. NEUROCHEMISTRY INTERNATIONAL
- Genome-wide association study confirms extant PD risk loci among the Dutch
- (2011) Javier Simón-Sánchez et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain
- (2010) Dario Domenico Lofrumento et al. NEUROIMMUNOMODULATION
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More